炎症性肠病患者的肠外恶性肿瘤风险:基于人群队列研究的系统评价与Meta分析
该系统评价与Meta分析纳入40项基于人群的队列研究(其中15项进入Meta分析),评估炎症性肠病患者肠外恶性肿瘤风险。
要点
- 克罗恩病和溃疡性结肠炎患者皮肤及肝胆恶性肿瘤风险均升高,克罗恩病患者血液和肺部恶性肿瘤风险也升高。
核心结论
- 克罗恩病和溃疡性结肠炎患者肠外恶性肿瘤总体风险及特定部位风险均升高,但需更长随访的额外研究评估炎症性肠病所致肠外恶性肿瘤的真实风险。
研究设计与样本
- 系统评价与Meta分析,仅纳入报告肠外恶性肿瘤患病率或发病率的基于人群的研究。
- 共筛选884项研究,40项纳入系统评价,15项纳入Meta分析。
局限性
- 需要更长随访的额外研究来评估炎症性肠病所致肠外恶性肿瘤的真实风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Patients with Crohn's disease (CD) and ulcerative colitis (UC) are at increased risk of developing intestinal cancer. However, less is known about the risk of extraintestinal cancers (EICs). The aim of this study was to conduct a systematic review and meta-analysis of population-based cohorts assessing the risk of EICs in inflammatory bowel disease (IBD) patients. METHODS: Only population-based studies reporting on the prevalence or incidence of EICs were included. In total, 884 studies were screened and those included were assessed for quality. Eligible studies were pooled for length of follow-up evaluation, events in the IBD population, and events or expected events in a control population for the meta-analyses. RESULTS: In total, 40 studies were included in the systematic review and 15 studies were included in the meta-analysis. The overall risk of EICs was found to be increased in both CD (incidence rate ratio [IRR]: 1.43 [CI, 1.26, 1.63]) and UC (IRR: 1.15 [1.02, 1.31]) patients. Both CD and UC patients presented with an increased risk of skin (IRR: CD, 2.22 [1.41-3.48]; UC, 1.38 [1.12-1.71]) and hepatobiliary (IRR: CD, 2.31 [1.25-4.28]; UC, 2.05 [1.52-2.76]) malignancies. Furthermore, CD patients showed an increased risk of hematologic (IRR, 2.40 [1.81-3.18]) and lung (IRR, 1.53 [1.23-1.91]) cancers. These increased risks were present despite treatment with immunosuppressives. CONCLUSIONS: This systematic review and meta-analysis shows that both CD and UC patients are at an increased risk of developing EICs, both overall and at specific sites. However, additional studies with longer follow-up evaluation are needed to assess the true risk of EICs posed by IBD.
引用
- Lo B, Zhao M, Vind I, et al. The Risk of Extraintestinal Cancer in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis of Population-based Cohort Studies. Clin Gastroenterol Hepatol. 2020. PMID: 32801010. doi:10.1016/j.cgh.2020.08.015
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。